Drug Type Small molecule drug |
Synonyms RTI-1092663 |
Target |
Action inverse agonists |
Mechanism CB1 inverse agonists(Cannabinoid CB1 receptor inverse agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Abdominal Obesity Metabolic Syndrome | Preclinical | United States | - |